American Portfolios Advisors’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

American Portfolios Advisors’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$90	Hold	30	–	–	﹤0.01%	3486
2022 Q2	$75	Hold	30	–	–	﹤0.01%	3489
2022 Q1	$233	Hold	30	–	–	﹤0.01%	3523
2021 Q4	$125	Hold	30	–	–	﹤0.01%	3477
2021 Q3	$238	Hold	30	–	–	﹤0.01%	3424
2021 Q2	$242	Hold	30	–	–	﹤0.01%	3352
2021 Q1	$322	Hold	30	–	–	﹤0.01%	3232
2020 Q4	$353	Hold	30	–	–	﹤0.01%	2920
2020 Q3	$361	Buy	+30	New	+$410	﹤0.01%	2871

Other funds holding FUSN

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

American Portfolios Advisors's FUSN Position: Q3 2022 in Review

American Portfolios Advisors held its Fusion Pharmaceuticals Inc. Common Shares (FUSN) position steady in Q3 2022 at 30 shares worth $90. The position accounts for ﹤0.01% of the portfolio, ranked #3486.

American Portfolios Advisors first reported a position in FUSN in Q3 2020 and has held it in 9 quarters since. The position peaked at $361 in Q3 2020. 34 funds tracked by Wall St. Rank hold FUSN as of Q3 2022.

American Portfolios Advisors held 30 shares of Fusion Pharmaceuticals Inc. Common Shares worth $90 as of Q3 2022.
American Portfolios Advisors left its Fusion Pharmaceuticals Inc. Common Shares share count unchanged in Q3 2022.
Fusion Pharmaceuticals Inc. Common Shares made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3486 holding.
American Portfolios Advisors first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2020 and has held it in 9 quarters since.
American Portfolios Advisors's Fusion Pharmaceuticals Inc. Common Shares position peaked at $361 in Q3 2020.
34 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.